Page last updated: 2024-08-24

valsartan and Cardiac Diseases

valsartan has been researched along with Cardiac Diseases in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's2 (18.18)29.6817
2010's4 (36.36)24.3611
2020's4 (36.36)2.80

Authors

AuthorsStudies
Huynh, K1
Ge, T; Yang, Y; Zhao, Y1
El Nozahi, M; Rezq, A; Saad, M1
Chandrabhatla, AS; Christiansen, SL; Holmes, JW; Nelson, AR; Saucerman, JJ; Zeigler, AC1
Abdel Fattah, SM; Ibrahim, DM; Radwan, RR1
Dai, M; Qian, D; Tao, H; Zhang, C1
Arya, DS; Bharti, S; Goyal, S; Sahoo, KC; Sharma, AK1
Bozcali, E; Dedeoglu, DB; Karpuz, H; Karpuz, V; Suzer, O1
Cohn, JN; Duprez, DA; Florea, ND; Jones, K1
Coca, A; Giner, V1
Corvol, P; Plouin, PF1

Reviews

2 review(s) available for valsartan and Cardiac Diseases

ArticleYear
[Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
    Revista espanola de cardiologia, 1999, Volume: 52 Suppl 3

    Topics: Aged; Angiotensin II; Angiotensin Receptor Antagonists; Anti-Arrhythmia Agents; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Clinical Trials as Topic; Heart Diseases; Heart Failure; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan

1999
[Angiotensin II receptor blockers: current status and future prospects].
    Drugs, 2002, Volume: 62 Spec No 1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Heart Diseases; Humans; Hypertension; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan

2002

Trials

4 trial(s) available for valsartan and Cardiac Diseases

ArticleYear
A study of the efficacy of sacubitril/valsartan plus dapagliflozin combination treatment in pulmonary arterial hypertension due to left heart disease.
    Perfusion, 2023, Volume: 38, Issue:8

    Topics: Heart Diseases; Heart Failure; Humans; Pulmonary Arterial Hypertension; Stroke Volume; Valsartan; Ventricular Function, Left

2023
Comparison of the Efficacy and Safety of Sacubitril/Valsartan versus Ramipril in Patients With ST-Segment Elevation Myocardial Infarction.
    The American journal of cardiology, 2021, 03-15, Volume: 143

    Topics: Adult; Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Double-Blind Method; Drug Combinations; Female; Heart Diseases; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Ramipril; ST Elevation Myocardial Infarction; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan

2021
Clinical efficacy and ultrasound inspection of the treatment of hypertensive heart patients with Valsartan combined with hydrochlorothiazide.
    Pakistan journal of pharmaceutical sciences, 2018, Volume: 31, Issue:4(Special)

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Echocardiography; Female; Heart Diseases; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Treatment Outcome; Valsartan; Ventricular Function, Left

2018
Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities: the DETECTIV Pilot Study.
    Journal of the American College of Cardiology, 2007, Aug-28, Volume: 50, Issue:9

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Cardiovascular Diseases; Comorbidity; Coronary Artery Disease; Disease Progression; Double-Blind Method; Exercise Test; Female; Fluorescein Angiography; Health Status Indicators; Heart Diseases; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Pilot Projects; Predictive Value of Tests; Tetrazoles; Valine; Valsartan

2007

Other Studies

5 other study(ies) available for valsartan and Cardiac Diseases

ArticleYear
Valsartan attenuates cardiac dysfunction and remodelling in patients with HCM.
    Nature reviews. Cardiology, 2021, Volume: 18, Issue:12

    Topics: Aminobutyrates; Heart Diseases; Humans; Stroke Volume; Valsartan

2021
Network model-based screen for FDA-approved drugs affecting cardiac fibrosis.
    CPT: pharmacometrics & systems pharmacology, 2021, Volume: 10, Issue:4

    Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Animals; Arsenic Trioxide; Biphenyl Compounds; Computer Simulation; Drug Combinations; Fibroblasts; Fibrosis; Heart Diseases; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Models, Animal; Network Pharmacology; Pyrazoles; Quaternary Ammonium Compounds; Quinolines; Rats; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad3 Protein; Thioctic Acid; Valsartan

2021
Antioxidant and antiapoptotic effects of sea cucumber and valsartan against doxorubicin-induced cardiotoxicity in rats: The role of low dose gamma irradiation.
    Journal of photochemistry and photobiology. B, Biology, 2017, Volume: 170

    Topics: Animals; Antioxidants; Apoptosis; Aspartate Aminotransferases; Caspase 3; Creatine Kinase; Doxorubicin; Gamma Rays; Glutathione; Heart Diseases; Male; Myocardium; Nitric Oxide Synthase Type II; Oxidative Stress; Peroxidase; Rats; Reactive Oxygen Species; Sea Cucumbers; Troponin I; Valsartan

2017
Valsartan, an angiotensin II receptor blocker, attenuates cardiac dysfunction and oxidative stress in isoproterenol-induced cardiotoxicity.
    Cardiovascular toxicology, 2011, Volume: 11, Issue:2

    Topics: Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cardiotonic Agents; Cardiotoxins; Heart Diseases; Heart Rate; Isoproterenol; Male; Oxidative Stress; Rats; Rats, Wistar; Tetrazoles; Valine; Valsartan

2011
Cardioprotective effects of zofenopril, enalapril and valsartan against ischaemia/reperfusion injury as well as doxorubicin cardiotoxicity.
    Acta cardiologica, 2012, Volume: 67, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Doxorubicin; Enalapril; Heart Diseases; Hemodynamics; Humans; Male; Rats; Rats, Wistar; Reperfusion Injury; Tetrazoles; Valine; Valsartan

2012